WASHINGTON - The House last week brushed off a major challenge to patent legislation that is strongly supported by the biotechnology industry.

The House voted 227-178 to reject Rep. Dana Rohrabacher's (R-Calif.) substitute for H.R. 400, the 21st Century Patent System Improvement Act. The vote paves the way for passage of the omnibus bill, which the Clinton administration supports.